Skip to main content
Erschienen in: Diabetologia 12/2006

01.12.2006 | Article

Decreased protein levels of key insulin signalling molecules in adipose tissue from young men with a low birthweight – potential link to increased risk of diabetes?

verfasst von: S. E. Ozanne, C. B. Jensen, K. J. Tingey, M. S. Martin-Gronert, L. Grunnet, C. Brons, H. Storgaard, A. A. Vaag

Erschienen in: Diabetologia | Ausgabe 12/2006

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

Individuals with low birthweight are at increased risk of type 2 diabetes mellitus. However, the underlying molecular mechanisms are unknown. Previously we have shown that low birthweight is associated with changes in muscle insulin signalling proteins. Here we determined whether low birthweight is associated with changes in insulin signalling proteins in adipose tissue.

Methods

Men (age 23 years) with either a low (bottom 10th percentile) (n = 17) or a normal (50th–90th percentile) (n = 17) birthweight were recruited from the Danish Medical Birth Registry and subcutaneous adipose biopsies were taken.

Results

Between the two groups there was no difference in protein level of the insulin receptor, protein kinase C zeta, glycogen synthase kinase-3 (GSK3) alpha, GSK3 beta, protein kinase B alpha and beta, peroxisome proliferative activated receptor gamma coactivator 1 or Src-homology-2-containing protein. However, the levels of GLUT4 (also known as solute carrier family 2 [facilitated glucose transporter], member 4 [SLC2A4]) (52 ± 10.9% reduction, p < 0.01), p85α subunit of phosphoinositide 3-kinase (PI3K) (45 ± 9% reduction, p < 0.01), p110ß subunit of PI3K (48 ± 17% reduction, p = 0.06) and IRS1 (59 ± 24% reduction, p < 0.05) were reduced in men of low birthweight.

Conclusions/interpretation

These findings show that low birthweight is associated with reduced levels of adipose insulin signalling proteins, thus providing a potential molecular framework to explain why people with low birthweight are at increased risk of developing type 2 diabetes. These differences precede the development of diabetes and thus may help predict disease risk.
Literatur
2.
Zurück zum Zitat Poulsen P, Vaag AA, Kyvik KO, Moller Jensen D, Beck-Nielsen H (1997) Low birthweight is associated with NIDDM in discordant monozygotic and dizygotic twin pairs. Diabetologia 40:439–446PubMedCrossRef Poulsen P, Vaag AA, Kyvik KO, Moller Jensen D, Beck-Nielsen H (1997) Low birthweight is associated with NIDDM in discordant monozygotic and dizygotic twin pairs. Diabetologia 40:439–446PubMedCrossRef
3.
Zurück zum Zitat Bo S, Cavallo-Perin P, Scaglione L, Ciccone G, Pagano G (2000) Low birthweight and genetic abnormalities in twins with increased susceptibility to type 2 diabetes mellitus. Diabet Med 17:365–370PubMedCrossRef Bo S, Cavallo-Perin P, Scaglione L, Ciccone G, Pagano G (2000) Low birthweight and genetic abnormalities in twins with increased susceptibility to type 2 diabetes mellitus. Diabet Med 17:365–370PubMedCrossRef
4.
Zurück zum Zitat Iliadou A, Cnattingius S, Lichtenstein P (2004) Low birthweight and type 2 diabetes: a study on 11162 Swedish twins. Int J Epidemiol 33:953–954CrossRef Iliadou A, Cnattingius S, Lichtenstein P (2004) Low birthweight and type 2 diabetes: a study on 11162 Swedish twins. Int J Epidemiol 33:953–954CrossRef
5.
Zurück zum Zitat Ravelli AC, Van der Meulen JH, Michels RP et al (1998) Glucose intolerance in adults after prenatal exposure to famine. Lancet 351:173–177PubMedCrossRef Ravelli AC, Van der Meulen JH, Michels RP et al (1998) Glucose intolerance in adults after prenatal exposure to famine. Lancet 351:173–177PubMedCrossRef
6.
Zurück zum Zitat Ozanne SE, Jensen CB, Tingey KJ, Storgaard H, Madsbad S, Vaag AA (2005) Low birthweight is associated with specific changes in muscle insulin-signalling protein expression. Diabetologia 48:547–552PubMedCrossRef Ozanne SE, Jensen CB, Tingey KJ, Storgaard H, Madsbad S, Vaag AA (2005) Low birthweight is associated with specific changes in muscle insulin-signalling protein expression. Diabetologia 48:547–552PubMedCrossRef
7.
Zurück zum Zitat Randle PJ, Garland PB, Hales CN, Newsholme EA (1963) The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1:785–789PubMedCrossRef Randle PJ, Garland PB, Hales CN, Newsholme EA (1963) The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1:785–789PubMedCrossRef
8.
Zurück zum Zitat Graham TE, Yang Q, Bluher M et al (2006) Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Eng J Med 354:2552–2563CrossRef Graham TE, Yang Q, Bluher M et al (2006) Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Eng J Med 354:2552–2563CrossRef
9.
Zurück zum Zitat Rajala MW, Scherer PE (2003) Mini review: the adipocyte at the crossroads of energy homeostasis, inflammation and atherosclerosis. Endocrinology 144:3765–3773PubMedCrossRef Rajala MW, Scherer PE (2003) Mini review: the adipocyte at the crossroads of energy homeostasis, inflammation and atherosclerosis. Endocrinology 144:3765–3773PubMedCrossRef
10.
Zurück zum Zitat Shepherd PR, Gnudi L, Tozzo E, Yang H, Leach F, Kahn BB (1993) Adipose tissue hyperplasia and enhanced glucose disposal in transgenic mice over-expressing GLUT 4 selectively in adipose tissue. J Biol Chem 268:22243–22246PubMed Shepherd PR, Gnudi L, Tozzo E, Yang H, Leach F, Kahn BB (1993) Adipose tissue hyperplasia and enhanced glucose disposal in transgenic mice over-expressing GLUT 4 selectively in adipose tissue. J Biol Chem 268:22243–22246PubMed
11.
Zurück zum Zitat Abel ED, Peroni O, Kim JK et al (2001) Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature 409:729–733PubMedCrossRef Abel ED, Peroni O, Kim JK et al (2001) Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature 409:729–733PubMedCrossRef
12.
Zurück zum Zitat Rasmussen EL, Malis C, Jensen CB et al (2005) Altered fat distribution in young adult men who had low birthweight. Diabetes Care 28(1):151–153PubMed Rasmussen EL, Malis C, Jensen CB et al (2005) Altered fat distribution in young adult men who had low birthweight. Diabetes Care 28(1):151–153PubMed
13.
Zurück zum Zitat McCance DR, Pettitt DJ, Hanson RL, Jacobsson LT, Knowler WC, Bennett PH (1994) Birthweight and non-insulin dependent diabetes: thrifty genotype, thrifty phenotype or surviving small baby genotype? Br Med J 308:942–945 McCance DR, Pettitt DJ, Hanson RL, Jacobsson LT, Knowler WC, Bennett PH (1994) Birthweight and non-insulin dependent diabetes: thrifty genotype, thrifty phenotype or surviving small baby genotype? Br Med J 308:942–945
14.
Zurück zum Zitat Jensen CB, Storgaard H, Dela F, Holst JJ, Madsbad S, Vaag AA (2002) Early differential defects of insulin secretion and action in 19-year old Caucasian men who had low birthweight. Diabetes 51:1271–1280PubMed Jensen CB, Storgaard H, Dela F, Holst JJ, Madsbad S, Vaag AA (2002) Early differential defects of insulin secretion and action in 19-year old Caucasian men who had low birthweight. Diabetes 51:1271–1280PubMed
15.
Zurück zum Zitat Schou JH, Pilgaard K, Vilsboll T et al (2005) Normal secretion and action of the gut incretin-like peptide-1 and glucose dependent insulinotropic polypeptide in young men with low birthweight. J Clin Endocrinol Metab 90:4912–4919PubMedCrossRef Schou JH, Pilgaard K, Vilsboll T et al (2005) Normal secretion and action of the gut incretin-like peptide-1 and glucose dependent insulinotropic polypeptide in young men with low birthweight. J Clin Endocrinol Metab 90:4912–4919PubMedCrossRef
16.
17.
Zurück zum Zitat Poy MN, Eliasson L, Krutzfeldt J et al (2004) A pancreatic islet-specific microRNA regulates insulin secretion. Nature 423:226–230CrossRef Poy MN, Eliasson L, Krutzfeldt J et al (2004) A pancreatic islet-specific microRNA regulates insulin secretion. Nature 423:226–230CrossRef
18.
Zurück zum Zitat Esau C, Kang X, Peralta E et al (2004) Micro RNA-143 regulates adipocyte differentiation. J Biol Chem 279:52361–52365PubMedCrossRef Esau C, Kang X, Peralta E et al (2004) Micro RNA-143 regulates adipocyte differentiation. J Biol Chem 279:52361–52365PubMedCrossRef
19.
Zurück zum Zitat Shepherd PR, Kahn BB (1999) Glucose transporters and insulin action — implications for insulin resistance and diabetes mellitus. N Eng J Med 341:248–257CrossRef Shepherd PR, Kahn BB (1999) Glucose transporters and insulin action — implications for insulin resistance and diabetes mellitus. N Eng J Med 341:248–257CrossRef
20.
Zurück zum Zitat Rondinone CM, Wang LM, Lonnroth P, Wesslau C, Pierce JH, Smith U (1997) Insulin receptor substrate (IRS) 1 is reduced and IRS-2 is the main docking protein for phosphatidylinositol 3-kinase in adipocytes from subjects with non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci 94:4171–4175PubMedCrossRef Rondinone CM, Wang LM, Lonnroth P, Wesslau C, Pierce JH, Smith U (1997) Insulin receptor substrate (IRS) 1 is reduced and IRS-2 is the main docking protein for phosphatidylinositol 3-kinase in adipocytes from subjects with non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci 94:4171–4175PubMedCrossRef
21.
Zurück zum Zitat Smith U, Axelson M, Carvalho E, Eliasson B, Jansson PA, Wesslau C (1999) Insulin signalling and action in fat cells: associations with insulin resistance and type 2 diabetes. Ann N Y Acad Sci 892:119–126PubMedCrossRef Smith U, Axelson M, Carvalho E, Eliasson B, Jansson PA, Wesslau C (1999) Insulin signalling and action in fat cells: associations with insulin resistance and type 2 diabetes. Ann N Y Acad Sci 892:119–126PubMedCrossRef
22.
Zurück zum Zitat Ozanne SE, Nave BT, Wang CL, Shepherd PR, Prins J, Smith GD (1997) Poor fetal nutrition causes long-term changes in expression of insulin signalling components in adipocytes. Am J Physiol Endocrinol Metab 273:E46–E51 Ozanne SE, Nave BT, Wang CL, Shepherd PR, Prins J, Smith GD (1997) Poor fetal nutrition causes long-term changes in expression of insulin signalling components in adipocytes. Am J Physiol Endocrinol Metab 273:E46–E51
23.
Zurück zum Zitat Rondinone CM, Carvalho E, Wesslau C, Smith UP (1999) Impaired glucose transport and protein kinase B activation by insulin, but not okadaic acid in adipocytes from subjects with type 2 diabetes mellitus. Diabetologia 42:819–825PubMedCrossRef Rondinone CM, Carvalho E, Wesslau C, Smith UP (1999) Impaired glucose transport and protein kinase B activation by insulin, but not okadaic acid in adipocytes from subjects with type 2 diabetes mellitus. Diabetologia 42:819–825PubMedCrossRef
24.
Zurück zum Zitat Hermann TS, Rask-Madsen C, Ihlemann N et al (2003) Normal insulin-stimulated endothelial function and impaired insulin-stimulated muscle glucose uptake in young adults with low birthweight. J Clin Endocrinol Metab 88:1252–1257PubMedCrossRef Hermann TS, Rask-Madsen C, Ihlemann N et al (2003) Normal insulin-stimulated endothelial function and impaired insulin-stimulated muscle glucose uptake in young adults with low birthweight. J Clin Endocrinol Metab 88:1252–1257PubMedCrossRef
25.
Zurück zum Zitat Law CM, Barker DJ, Osmond C, Fall CH, Simmonds SJ (1992) Early growth and abdominal fatness in adult life. J Epidemiol Community Health 46:184–186PubMedCrossRef Law CM, Barker DJ, Osmond C, Fall CH, Simmonds SJ (1992) Early growth and abdominal fatness in adult life. J Epidemiol Community Health 46:184–186PubMedCrossRef
26.
Zurück zum Zitat Hales CN, Barker DJ, Clark PM et al (1991) Fetal and infant growth and impaired glucose tolerance at age 64. Br Med J 303:1019–1022CrossRef Hales CN, Barker DJ, Clark PM et al (1991) Fetal and infant growth and impaired glucose tolerance at age 64. Br Med J 303:1019–1022CrossRef
Metadaten
Titel
Decreased protein levels of key insulin signalling molecules in adipose tissue from young men with a low birthweight – potential link to increased risk of diabetes?
verfasst von
S. E. Ozanne
C. B. Jensen
K. J. Tingey
M. S. Martin-Gronert
L. Grunnet
C. Brons
H. Storgaard
A. A. Vaag
Publikationsdatum
01.12.2006
Verlag
Springer-Verlag
Erschienen in
Diabetologia / Ausgabe 12/2006
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-006-0466-2

Weitere Artikel der Ausgabe 12/2006

Diabetologia 12/2006 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.